Evidence map›Paper›PMID 24116229›Full record

ArticlePloS one2013

ω3-PUFAs exert anti-inflammatory activity in visceral adipocytes from colorectal cancer patients.

Massimo D'Archivio, Beatrice Scazzocchio, Stefania Giammarioli, Maria L Fiani, Rosaria Varì, Carmela Santangelo, Augusto Veneziani, Annunziata Iacovelli, Claudio Giovannini, Sandra Gessani and 1 more

Retracted Registry-linked trialOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. It is linked to trial NCT04042519 (The Correlation Research Between the Omega-3 and Omega-6 Inflammatory Metabolites and Stable COPD.), which is not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04042519 completednot on this mapstarted 2016, after this paper: background citation

The Correlation Research Between the Omega-3 and Omega-6 Inflammatory Metabolites and Stable COPD.

TypeobservationalSponsorGuangzhou Institute of Respiratory DiseaseRan2016 to 2019Enrolled200ConditionsMetabolomics, Omega 6, Omega 3, COPDArmsLung function test was performed on the subjects with Jaeger lung function instrument of Germany., Agilent 1290 Infinity LC system (UHPLC, Santa Clara CA) was used for Targeted metabolite detection., Routine blood test
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Very-long-chainThe American journal of clinical nutrition · 2017
    Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Mechanisms by Which Pleiotropic AmphiphilicCurrent colorectal cancer reports · 2014
    Article
  19. Obesity and cancer pathogenesis.Annals of the New York Academy of Sciences · 2014
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Massimo D'ArchivioDepartment Veterinary Public Health and Food Safety, Rome, Italy.
Beatrice Scazzocchio
Stefania Giammarioli
Maria L Fiani
Rosaria Varì
Carmela Santangelo
Augusto Veneziani
Annunziata Iacovelli
Claudio Giovannini
Sandra Gessani
Roberta Masella
Istituto Superiore di Sanità · ITUniversità Cattolica del Sacro Cuore · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to correlate specific fatty acid profiles of visceral white adipose tissue (WAT) with inflammatory signatures potentially associated with colorectal cancer (CRC).

methodsHuman adipocytes were isolated from biopsies of visceral WAT from 24 subjects subdivided in four groups: normal-weight (BMI 22.0-24.9 Kg/m2) and over-weight/obese (BMI 26.0-40.0 Kg/m2), affected or not by CRC. To define whether obesity and/or CRC affect the inflammatory status of WAT, the activation of the pro-inflammatory STAT3 and the anti-inflammatory PPARγ transcription factors as well as the expression of adiponectin were analyzed by immunoblotting in adipocytes isolated from each group of subjects. Furthermore, to evaluate whether differences in inflammatory WAT environment correlate with specific fatty acid profiles, gas-chromatographic analysis was carried out on WAT collected from all subject categories. Finally, the effect of the ω3 docosahexaenoic acid treatment on the balance between pro- and anti-inflammatory factors in adipocytes was also evaluated.

resultsWe provide the first evidence for the existence of a pro-inflammatory environment in WAT of CRC patients, as assessed by the up-regulation of STAT3, and the concomitant decrease of PPARγ and adiponectin with respect to healthy subjects. WAT inflammatory status was independent of obesity degree but correlated with a decreased ω3-/ω6-polyunsaturated fatty acid ratio. These observations suggested that qualitative changes, other than quantitative ones, in WAT fatty acid may influence tissue dysfunctions potentially linked to inflammatory conditions. This hypothesis was further supported by the finding that adipocyte treatment with docosahexaenoic acid restored the equilibrium between STAT3 and PPARγ.

conclusionOur results suggest that adipocyte dysfunctions occur in CRC patients creating a pro-inflammatory environment that might influence cancer development. Furthermore, the protective potential of docosahexaenoic acid in re-establishing the equilibrium between pro- and anti-inflammatory factors might represent a useful tool for preventive and therapeutic strategies.

Indexed as

AdipocytesAdiponectinAgedAnti-Inflammatory AgentsCells, CulturedColorectal NeoplasmsFatty Acids, Omega-3FemaleHumansInterleukin-6Intra-Abdominal FatMaleMiddle AgedObesityPPAR gammaSTAT3 Transcription FactorAdiponectinAnti-Inflammatory AgentsFatty Acids, Omega-3Interleukin-6PPAR gammaSTAT3 Transcription Factor

Identifiers

PMID24116229
PMCPMC3792028
OpenAlexW2065833746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.